| Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor JP Zepecki, KM Snyder, MM Moreno, E Fajardo, A Fiser, J Ness, A Sarkar, ... Oncogene 38 (10), 1734-1750, 2019 | 68 | 2019 |
| Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells KM Snyder, R Hullsiek, HK Mishra, DC Mendez, Y Li, A Rogich, ... Frontiers in immunology 9, 2873, 2018 | 63 | 2018 |
| Autotransfecting short interfering RNA through facile covalent polymer escorts SE Averick, E Paredes, SK Dey, KM Snyder, N Tapinos, K Matyjaszewski, ... Journal of the American Chemical Society 135 (34), 12508-12511, 2013 | 51 | 2013 |
| Lck tyrosine kinase mediates β1-integrin signalling to regulate Schwann cell migration and myelination JK Ness, KM Snyder, N Tapinos Nature communications 4 (1), 1912, 2013 | 33 | 2013 |
| miRNA-mediated loss of m6A increases nascent translation in glioblastoma JP Zepecki, D Karambizi, JE Fajardo, KM Snyder, C Guetta-Terrier, ... PLoS genetics 17 (3), e1009086, 2021 | 26 | 2021 |
| Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade KL Anderson, KM Snyder, D Ito, DC Lins, LJ Mills, K Weiskopf, NG Ring, ... Melanoma research 30 (2), 147, 2020 | 16 | 2020 |
| Sustained local release of methylprednisolone from a thiol-acrylate poly (ethylene glycol) hydrogel for treating chronic compressive radicular pain JR Slotkin, JK Ness, KM Snyder, AA Skiles, EJ Woodard, T O'Shea, ... Spine 41 (8), E441-E448, 2016 | 12 | 2016 |
| Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer GrowthNK-92 CD64 Cell Combo with Antitumor … HM Hintz, KM Snyder, J Wu, R Hullsiek, JD Dahlvang, GT Hart, ... Cancer immunology research 9 (11), 1270-1282, 2021 | 9 | 2021 |
| Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells R Hullsiek, Y Li, KM Snyder, S Wang, D Di, A Borgatti, C Lee, PF Moore, ... Frontiers in immunology 13, 2022 | 6 | 2022 |
| Ectodomain shedding by ADAM17 (a disintegrin and metalloproteinase 17) in canine neutrophils KM Snyder, CA McAloney, JS Montel, JF Modiano, B Walcheck Veterinary immunology and immunopathology 231, 110162, 2021 | 5 | 2021 |
| Subventricular zone adult mouse neural stem cells require insulin receptor for self-renewal S Chidambaram, FJ Velloso, DE Rothbard, K Deshpande, Y Cajuste, ... Stem Cell Reports 17 (6), 1411-1427, 2022 | 4 | 2022 |
| Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCC K Dixon, R Hullsiek, K Snyder, Z Davis, M Khaw, T Lee, HY Chu, ... Blood 136, 10-11, 2020 | 3 | 2020 |
| Subventricular zone adult mouse neural stem cells and human glioblastoma stem cells require insulin receptor for self-renewal S Chidambaram, D Rothbard, K Deshpande, Y Cajuste, KM Snyder, ... bioRxiv, 2020.03. 10.985598, 2020 | 2 | 2020 |
| Real-Time Monitoring of Human Glioma Cell Migration on Dorsal Root Ganglion Axon-Oligodendrocyte Co-Cultures JP Zepecki, KM Snyder, N Tapinos JoVE (Journal of Visualized Experiments), e59744, 2019 | 1 | 2019 |
| GENE-25. Loss OF m6A RNA methylation during glioma stem cell differentiation is regulated by miRNAs and promotes translation efficiency J Zepecki, E Fajardo, K Snyder, C Guetta-Terrier, O Tang, A Sarkar, ... Neuro-Oncology 20 (Suppl 6), vi108, 2018 | 1 | 2018 |
| Sustained Local Release of Methylprednisolone from a thiol-acrylate poly (ethylene glycol) Hydrogel for Treating Chronic Compressive Radicular Pain JR Slotkin, J Ness, K Snyder, A Skiles, E Woodard, T O'Shea, F Reynolds, ... JOURNAL OF NEUROSURGERY 122 (6), A1576-A1576, 2015 | 1 | 2015 |
| Ablation of SYK kinase from primary human Natural Killer cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production JD Dahlvang, JK Dick, JA Sangala, EJ Pomeroy, KM Snyder, ... bioRxiv, 2022.05. 29.493889, 2022 | | 2022 |
| Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for Cancer K Dixon, K Snyder, M Khaw, R Hullsiek, Z Davis, T Lee, H Chu, P Rogers, ... Blood 138, 406, 2021 | | 2021 |
| 197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells K Snyder, K Dixon, M Khaw, Z Davis, P Rogers, M Hosking, R Bjordahl, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Enhancing ADCC by human natural killer cells to improve tumor cell killing KM Snyder, R Hullsiek, HK Mishra, KJ Dixon, DC Mendez, Y Li, A Rogich, ... The Journal of Immunology 204 (1_Supplement), 239.26-239.26, 2020 | | 2020 |
